National Cancer Center - Academic Profile

Publications

Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC

Suresh S. Ramalingam , Johan Vansteenkiste , David Planchard +21 more

Among patients with previously untreated advanced NSCLC with an <i>EGFR</i> mutation, those who received osimertinib had longer overall survival than those who received a compar...

2019 New England Journal of Medicine 2577 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi , Cristina Saura , Toshinari Yamashita +22 more

Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...

2019 New England Journal of Medicine 1788 citations

Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma

Makoto Nishio , Takeharu Yamanaka , Kazuko Matsumoto +12 more

2011 Journal of Thoracic Oncology 7 citations

Affiliated Researchers

Fumiaki Koizumi

National Cancer Center

Institution Info

Type: nonprofit
Country: US
Publications: 3
Citations: 4,372

External Links

Identifiers

ROR: https://ror.org/0065zqt33